Description

Ingalar Inhalation 25 ml

Ingredients

Ingalar Inhalation contains the active ingredient fluticasone propionate, which is a corticosteroid. It also includes inactive ingredients such as propellant HFA-134a.

Dosage

The recommended dosage of Ingalar Inhalation is usually 2 inhalations twice a day. The dosage may vary depending on the condition being treated. It is important to follow the instructions provided by your healthcare provider.

Indications

Ingalar Inhalation is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. It helps to reduce inflammation in the airways, making it easier to breathe.

Contraindications

Do not use Ingalar Inhalation if you are allergic to fluticasone propionate or any other ingredients in the inhaler. It is important to discuss any existing medical conditions with your healthcare provider before starting this medication.

Directions

To use Ingalar Inhalation, shake the inhaler well before each use. Breathe out slowly, place the inhaler in your mouth, and inhale deeply. Hold your breath for a few seconds before exhaling. Rinse your mouth with water after each use to prevent thrush.

Scientific Evidence

Studies have shown that fluticasone propionate, the active ingredient in Ingalar Inhalation, is effective in reducing asthma symptoms and improving lung function. Research published in the Journal of Allergy and Clinical Immunology has demonstrated the efficacy of fluticasone propionate in controlling asthma exacerbations.

Additional Information

It is important to use Ingalar Inhalation regularly as prescribed by your healthcare provider, even if you are not experiencing any asthma symptoms. This medication is not a rescue inhaler and should not be used to treat sudden asthma attacks. Always carry a quick-relief inhaler with you for emergencies.

Pharmacologically, fluticasone propionate exerts its effects by reducing inflammation in the airways, thereby decreasing the frequency of asthma symptoms. It acts locally in the lungs and has minimal systemic side effects when used at recommended doses.

Clinical trials have shown that Ingalar Inhalation is comparable in efficacy to other inhaled corticosteroids used for asthma management. A study published in the European Respiratory Journal found that fluticasone propionate was well-tolerated and effective in improving lung function in patients with asthma.